ethyl (1R,5S,6R)-2-oxobicyclo[3.1.0]hexane-6-carboxylate, 97%, 50mg

Methyl 2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 250mg

Ethyl 1-(2-bromoacetyl)piperidine-4-carboxylate, 95+%, 250mg

3-(3-Methyl-3-butenyl)benzoic acid, 97.0%, 1g

Butanedioic acid, compd. with 4-amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide (1:1), 98.50%, 25g

3-Fluoro-4-nitroanisole, 95.0%, 10g

Methyl 3-methyl-1H-pyrazole-4-carboxylate, 95.0%, 1g

5'-(3-Formylphenyl)-[1,1':3',1''-terphenyl]-3,3''-dicarbaldehyde, 98%, 5g

3-(BOC-AMINO)-BICYCLO[1.1.1]PENTANE-1-METHANOL, 95.0%, 100mg

3-Trimethoxysilylpropyl 2-bromo-2-methyl-propionate, 99.48%, 5g

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2h-pyrazolo[3,4-b]pyridine, 98%, 500mg

Glycyl-DL-leucine>98.0%(T)1g

N-(4-Chlorophenyl)acrylamide, 95% (stabilized with MEHQ), 100mg